KPMG’s newest report on leading Life Sciences Clusters in Europe, released on 3 November 2015 at the Bio Europe Congress, reveals important differences between different countries in Europe and their attractiveness for Foreign Direct Investments for the Life Sciences Industry.
Rankings and indices play an important role in site selection. However, the devil is in the detail, and every ranking or index has to be critically questioned before being used to select a location.
Multinational companies (MNCs) are under an ever increasing pressure from their stakeholders and from the markets to provide for growth prospects which are at the same time competitive and sustainable. One of the key success factors in this regards is choosing the right location for the right activities.